Related Experiment Video
Updated: Jun 26, 2026
07:36
Induction of Atherosclerotic Plaques Through Activation of Mineralocorticoid Receptors in Apolipoprotein E-deficient Mice
Published on: September 26, 2018
Catechin reduces atherosclerotic lesion development in apo E-deficient mice: a transcriptomic study
Sylvain Auclair1, Dragan Milenkovic, Catherine Besson
1Unité de Nutrition Humaine UMR1019, INRA-Clermont Ferrand/Theix, 63122 Saint Genès Champanelle, France.
Atherosclerosis
|January 21, 2009
Summary
Dietary catechin supplementation reduced atherosclerotic lesion size in mice by 32%. This study utilized transcriptomics to reveal underlying mechanisms, identifying altered gene expression in lipid metabolism and adhesion molecules, offering new insights into flavonoid
Area of Science:
- Cardiovascular Research
- Nutritional Science
- Molecular Biology
Background:
- Dietary flavonoids, including catechin, are linked to cardiovascular protection.
- Atherosclerosis is a major cardiovascular disease driven by lipid accumulation and inflammation.
- Understanding the molecular mechanisms of flavonoid action is crucial for therapeutic development.
Purpose of the Study:
- To investigate the anti-atherosclerotic effects of dietary catechin in apolipoprotein E-deficient (apoE-/-) mice.
- To explore the molecular mechanisms of catechin's action using a transcriptomic approach.
- To assess catechin's impact on lesion development and related molecular pathways at a low nutritional level.
Main Methods:
- Supplementation of apoE-/- mice with catechin for 6 weeks.
- Assessment of atherosclerotic lesions via histomorphometry.
- Evaluation of plasma and liver lipid profiles, antioxidant capacity (FRAP), and inflammatory markers (serum amyloid A).
- Global gene expression analysis of aortic tissue using pangenomic arrays.
Main Results:
- Catechin supplementation significantly reduced atherosclerotic lesion area by 32%.
- No significant changes were observed in plasma or liver total cholesterol and triacylglycerol levels.
- Plasma antioxidant capacity and inflammatory status remained unchanged.
- Transcriptomic analysis revealed significant alterations in 450 genes, including down-regulation of adhesion molecules (e.g., CD34, PSGL-1) and genes involved in lipid metabolism (e.g., FABP4, LPL, SCARA5).
Conclusions:
- Dietary catechin exhibits anti-atherosclerotic effects in apoE-/- mice, even at low doses.
- Transcriptomic analysis provides a deeper understanding of catechin's mechanisms, highlighting its impact on gene expression related to leukocyte adhesion and lipid metabolism.
- This study demonstrates the utility of transcriptomics in identifying biological effects of low-dose flavonoids when traditional markers show no significant changes.
Related Concept Videos
01:26Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
01:30Atherosclerosis I: Introduction
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...